Congresswoman Robin Kelly Introduces Legislation to Expand Access to Lower Cost Generic Drugs
Congresswoman Robin Kelly, chair of the Congressional Black Caucus Health Braintrust and member of the Health subcommittee on Energy and Commerce, has introduced the Orange Book Transparency Act (H.R. 1503) to increase access to lower cost generic drugs and bolster competition within the generic drug marketplace to help reduce drug costs. The Orange Book is an important tool for the development and prescribing of generic drugs. Doctors and pharmacists use the Orange Book for information on the approval and availability of generic drugs. Likewise, generic companies use the Orange Book to make critical R&D decisions. Experts, medical professional and advocates